Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1588-1598

  Tsuji, Ryohei F ^a   Kawikova, Ivana ^b   Ramabhadran, Rajani ^b   Akahira Azuma, Moe ^b   Taub, Dennis ^c   Hugli, Tony E ^d   Gerard, Craig ^e   Askenase, Philip W ^b  

^a Noda Institute for Scientific Research   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CHEMOTAXIS; COMPLEMENT ACTIVATION; CONTACT SENSITIVITY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0034254650     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1588     Document Type: Article

References (47)

1. Askenase, P. W. 1998. Effector and regulatory molecules and mechanisms in delayed-type hypersensitivity (DTH). In Allergy: Principles and Practice, 5th Ed. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Atdkinson, Jr., J. W. Yunginger, and W. W. Busse, eds. Mosby, St. Louis, p. 323-341.
2. + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25: 3006.
3. Fong, T. A. T., and T. R. Mosmann. 1989. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:2887.
4. Marchal, G., M. Seman, G. Milon, P. Truffa-Bachi, and V. Zilberfarb. 1982. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J. Immunol. 129:954.
5. Grabbe, S., and T. Schwarz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19:37.
6. Springer, T. A. 1994. Traffic signals and leukocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
7. Grabbe, S., M. Steinert, K. Mahnke, A. Schwarz, T. A. Luger, and T. Schwarz. 1996. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice: evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J. Clin. Invest. 98:1158.
8. Van Loveren, H., and P. W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133:2397.
9. + T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 133:2402.
10. Van Loveren, H., R. Meade, and P. W. Askenase. 1983. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157:1604.
11. Geba, G. P., W. Ptak, G. M. Anderson, V. Paliwal, R. E. Ratzlaff, J. Levin, and P. W. Askenase. 1996. Delayed-type hypersensitivity in mast cell deficient mice: dependence on platelets for expression of contact sensitivity. J. Immunol. 157: 557.
12. Matsuda, H., G. P. Geba, and P. W. Askenase. 1997. Human platelets can initiate contact sensitivity through serotonin release mediated by IgE. J. Immunol. 158: 2891.
13. Askenase, P. W., S. Bursztajn, M. D. Gershon, and R. K. Gershon. 1980. T cell dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152:1358.
14. Schwartz, A., P. W. Askenase, and R. K. Gershon. 1977. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J. Immunol. 118:159.
15. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:673.
16. Schwarz, A., C. Kronke, F. Trautinger, Y. Aragane, P. Neuner, T. A. Luger, and T. Schwarz. 1993. Pentoxifylline suppresses irritant and contact hypersensitivity reactions. J. Invest. Dermatol. 101:549.
17. McHale, J. F., O. A. Harari, D. Marshall, and D. O. Haskard. 1999. Vascular endothelial cell expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 at the onset of eliciting contact hypersensitivity in mice: evidence for dominant role of TNFα. J. Immunol. 162:1648.
18. Tsuji, R. F., M. Kikuchi, and P. W. Askenase. 1996. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J. Immunol. 156:4644.
19. Tsuji, R. F., G. P. Geba, Y. Wang, K. Kawamoto, L. A. Matis, and P. W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell IFN-γ: a possible initiating role of B cells. J. Exp. Med. 186:1015.
20. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
21. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
22. Kraeuter-Kops, S., H. van Loveren, R. W. Rosenstein, W. Ptak, and P. W. Askenase. 1984. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen binding factor. Lab. Invest. 50:421.
23. Naraf, S., N. Davoust, R. S. Ames, and S. R. Barnum. 1999. Human T cells express C5a receptor and are chemoattracted to C5a. J. Immunol. 162:4018.
24. Mulligan, M. S., E. Schmid, G. O. Till, T. E. Hugh, H. P. Friedl, R. A. Roth, and P. A. Ward. 1997. C5a-dependent up-regulation in vivo of lung vascular P-selectin. J. Immunol. 158:1857.
25. Mulligan, M. S., E. Schmid, B. Beck-Schimmer, G. O. Till, H. P. Friedl, R. B. Brauer, T. E. Hugli, M. Miyasaka, R. L. Warner, K. J. Johnson, and P. A. Ward. 1996. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Immunol. 98:503.
26. Ramos, B. F., Y. Zhang, and B. A. Jakschik. 1994. Neutrophil elicitation in the reverse passive Arthus reaction: complement-dependent and -independent mast cell involvement. J. Immunol. 152:1380.
27. Hopken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1997. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186:749.
28. Frank, M. M., and L. F. Fries. 1991. The role of complement in inflammation and phagocytosis. Immunol. Today 12:322.
29. Hugli, T. K. 1981. Structural basis for anaphylatoxin and chemotactic functions of C3a, C4a and C5a. Crit. Rev. Immunol. 1:321.
30. Meuer, S., U. Ecker, U. Hadding, and D. Bitter-Suermann. 1981. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. J. Immunol. 126:1506.
31. Hopken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383:86.
32. Askenase, P. W., and B. J. Hayden. 1974. Cytophilic antibodies in mice contact sensitized with oxazolone: immunochemical characterization and preferential binding to a trypsin sensitive macrophage receptor. Immunology 27:563.
33. Ushio, H., R. F. Tsuji, M. Szczepanik, K. Keiko, H. Matsuda, and P. W. Askenase. 1998. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86). J. Immunol. 160:2080.
34. Lukacs, N. W., R. M. Strieter, K. Warmington, P. Lincoln, S. W. Chensue, and S. L. Kunkel. 1997. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J. Immunol. 158:4398.
35. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
36. Li, L., S. Sad., D. Kagi, and T. R. Mosmann. 1997. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158:4152.
37. + cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors. J. Immunol. 143:3125.
38. Ptak, W., W. R. Herzog, and P. W. Askenase. 1991. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J. Immunol. 146:469.
39. Schmid, E., M. T. Piccolo, H. P. Friedl, R. L. Warner, M. S. Mulligan, T. E. Hugli, T. Go, and P. A. Ward. 1997. Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock 8:119.
40. Kaplan, G., A. D. Luster, G. Hancock, and Z. A. Cohn. 1987. The expression of γ intereron-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166:1098.
41. Bokisch, V. A., and H. J. Muller-Eberhard. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427.
42. 8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 103:192.
43. Baggiolini, M. 1998. Chemokines and leukocytes traffic. Nature 392:565.
44. Gautam, S., J. Battisto, J. A. Major, D. Armstrong, M. Stoler, and T. A. Hamilton. 1994. Chemokine expression in trinitrochlorobenzene-mediated contact sensitivity. J. Leukocyte Biol. 55:452.
45. + T cells during the elicitation of contact hypersensitivity. J. Invest. Dermatol. 107:360.
46. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. L. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147.
47. Lim, H. W., S. Esquenazi-Behar, K. B. Yancey, and N. A. Soter. 1991. C5a, cutaneous mast cells, and inflammation: in vitro and in vivo studies in a murine model. J. Invest. Dermatol. 97:305.